Cardiff Oncology Stock (NASDAQ: CRDF) stock price, news, charts, stock research, profile.
Open | $2.52 |
Close | $2.68 |
Volume / Avg. | 1.00M / 551.08K |
Day Range | $2.51 - $2.71 |
52 Wk Range | 0.94 - 6.42 |
Market Cap | $125.68M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 63 |
Short Interest | 15.25% |
Days to Cover | 25.01 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Cardiff Oncology (NASDAQ:CRDF) through any online brokerage.
Other companies in Cardiff Oncology’s space includes: Anixa Biosciences (NASDAQ:ANIX), Citius Oncology (NASDAQ:CTOR), Adicet Bio (NASDAQ:ACET), Agenus (NASDAQ:AGEN) and FibroBiologics (NASDAQ:FBLG).
There is no analysis for Cardiff Oncology to provide a consensus price target.
The stock price for Cardiff Oncology (NASDAQ: CRDF) is $2.7 last updated September 20, 2024 at 5:16 PM EDT.
There are no upcoming dividends for Cardiff Oncology.
Cardiff Oncology does not have any upcoming earnings scheduled.
There is no upcoming split for Cardiff Oncology.
Cardiff Oncology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.